Works matching IS 15228517 AND DT 2024 AND VI 26 AND IP 2
Results: 17
Forthcoming Meetings.
- Published in:
- Neuro-Oncology, 2024, v. 26, n. 2, p. 397, doi. 10.1093/neuonc/noae003
- Publication type:
- Article
Oncolytic immunoactivation associates with survival in a glioblastoma clinical trial.
- Published in:
- Neuro-Oncology, 2024, v. 26, n. 2, p. 209, doi. 10.1093/neuonc/noad216
- By:
- Publication type:
- Article
A 34-gene expression biomarker predicts meningioma outcomes and radiotherapy responses.
- Published in:
- Neuro-Oncology, 2024, v. 26, n. 2, p. 207, doi. 10.1093/neuonc/noad212
- By:
- Publication type:
- Article
Lessons learned from phase 3 trials of immunotherapy for glioblastoma: Time for longitudinal sampling?
- Published in:
- Neuro-Oncology, 2024, v. 26, n. 2, p. 211, doi. 10.1093/neuonc/noad211
- By:
- Publication type:
- Article
Tumor-specific polycistronic miRNA delivered by engineered exosomes for the treatment of glioblastoma.
- Published in:
- Neuro-Oncology, 2024, v. 26, n. 2, p. 236, doi. 10.1093/neuonc/noad199
- By:
- Publication type:
- Article
Immune signatures of checkpoint inhibitor-induced autoimmunity—A focus on neurotoxicity.
- Published in:
- Neuro-Oncology, 2024, v. 26, n. 2, p. 279, doi. 10.1093/neuonc/noad198
- By:
- Publication type:
- Article
Branched-chain amino acid transaminase 1 regulates glioblastoma cell plasticity and contributes to immunosuppression.
- Published in:
- Neuro-Oncology, 2024, v. 26, n. 2, p. 251, doi. 10.1093/neuonc/noad190
- By:
- Publication type:
- Article
Radiotherapy-induced vascular cognitive impairment 20 years after childhood brain tumor.
- Published in:
- Neuro-Oncology, 2024, v. 26, n. 2, p. 362, doi. 10.1093/neuonc/noad186
- By:
- Publication type:
- Article
A combinatory vaccine with IMA950 plus varlilumab promotes effector memory T-cell differentiation in the peripheral blood of patients with low-grade gliomas.
- Published in:
- Neuro-Oncology, 2024, v. 26, n. 2, p. 335, doi. 10.1093/neuonc/noad185
- By:
- Publication type:
- Article
Brain tumors in United States military veterans.
- Published in:
- Neuro-Oncology, 2024, v. 26, n. 2, p. 387, doi. 10.1093/neuonc/noad182
- By:
- Publication type:
- Article
Improved early outcome prediction by MRI-based 3D tumor volume assessment in patients with CNS lymphomas.
- Published in:
- Neuro-Oncology, 2024, v. 26, n. 2, p. 374, doi. 10.1093/neuonc/noad177
- By:
- Publication type:
- Article
Glioma genetic profiles associated with electrophysiologic hyperexcitability.
- Published in:
- Neuro-Oncology, 2024, v. 26, n. 2, p. 323, doi. 10.1093/neuonc/noad176
- By:
- Publication type:
- Article
SRRM4-mediated REST to REST4 dysregulation promotes tumor growth and neural adaptation in breast cancer leading to brain metastasis.
- Published in:
- Neuro-Oncology, 2024, v. 26, n. 2, p. 309, doi. 10.1093/neuonc/noad175
- By:
- Publication type:
- Article
Indoximod-based chemo-immunotherapy for pediatric brain tumors: A first-in-children phase I trial.
- Published in:
- Neuro-Oncology, 2024, v. 26, n. 2, p. 348, doi. 10.1093/neuonc/noad174
- By:
- Publication type:
- Article
Integrating single-cell and spatial transcriptomics reveals endoplasmic reticulum stress-related CAF subpopulations associated with chordoma progression.
- Published in:
- Neuro-Oncology, 2024, v. 26, n. 2, p. 295, doi. 10.1093/neuonc/noad173
- By:
- Publication type:
- Article
NLGN4X TCR transgenic T cells to treat gliomas.
- Published in:
- Neuro-Oncology, 2024, v. 26, n. 2, p. 266, doi. 10.1093/neuonc/noad172
- By:
- Publication type:
- Article
Preclinical pediatric brain tumor models for immunotherapy: Hurdles and a way forward.
- Published in:
- Neuro-Oncology, 2024, v. 26, n. 2, p. 226, doi. 10.1093/neuonc/noad170
- By:
- Publication type:
- Article